Sirivichayakul, Chukiat <br/><br/>
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  01 2017 
 - 136-143 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2016.1234555  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Bacterial--blood<br/>Cell Survival--drug effects<br/>Diphtheria--prevention & control<br/>Diphtheria-Tetanus-acellular Pertussis Vaccines--administration & dosage<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Immunoglobulin G--blood<br/>Injections, Intramuscular<br/>Male<br/>Neutralization Tests<br/>Tetanus--prevention & control<br/>Thailand<br/>Whooping Cough--prevention & control<br/>Young Adult